Bracelet to test for knock-out drops

A method for detecting the presence of a knock-out drug, comprising:

• providing a wearable test strip bracelet for a human wrist, comprising:
• a band that comprises:
• two opposing ends;
• a closure mechanism configured to fasten the two opposing ends to one another and secure the band about a human wrist;
• and
• a front side comprising an outer wrist material layer, wherein the front side is configured to face directionally away from the human wrist when fastened;
• and
• a rear side comprising an inner wrist material layer, wherein the wrist side is configured to face directionally towards the human wrist when fastened;
• a test portion side comprising a test portion slot, wherein the test portion slot is configured to be between and parallel to the outer wrist material layer and the inner wrist material layer when fastened to the human wrist;
• a disposable and removeable test strip base;
• a plurality of fields, wherein the plurality of fields are configured to be disposed on the test strip base and each field comprises a dried chemical substance, wherein the dried chemical substance is configured to discolor into a first color tone and a second color tone in response to contact with a knock-out drug, and wherein the knock-out drug comprises at least one of Gamma-Hydroxybutyrate, Ketamine, Rohypnol, Flunitrazepam, Alprazolam and Diazepam;
• a test field portion comprising the disposable and removeable test strip base and the plurality of fields, wherein the test field portion is configured to fit into the test portion slot;
• a normal state color tone comprising the first color tone, wherein the first color tone of the dried chemical substance is configured to be dry and visible before starting a test for the presence of a knock-out drug within a sample of a fluid;
• a positive state color tone comprising the second color tone, wherein the second color tone is different from the first color tone, wherein an application of the sample of the fluid to at least one of the fields of the plurality of fields causes the dried chemical substance to turn into the second color tone if the sample of the fluid contains the knock- out drug;
• a first opening, wherein the first opening is a viewing opening configured to be disposed on the front side of the band and to visually display the test field portion;
• and
• a second opening, wherein the second opening is a test portion opening configured to be disposed on the test portion side of the band and to allow the insertion and withdrawal of the test strip base from the test portion slot;
• fastening the bracelet around a human wrist via the closure mechanism;
• obtaining a sample of fluid from a container via an applicator;
• applying the sample of the fluid to the at least one detection spot via the applicator;
• and
• detecting the presence or absence of a knock-out drug within the sample of the fluid by observing a change of color tone of the at least one detection spot, wherein a second color tone of the at least detection spot indicates the presence of the knock-out drug in the sample of the fluid, and a third color tone of the at least one detection spot indicates the absence of the knock- out drug in the sample of the fluid.

A method for detecting the presence of a knock-out drug, comprising:

• providing a wearable test strip bracelet for a human wrist, comprising:
• a band comprising:
• two opposing ends;
• a closure mechanism configured to fasten the two opposing ends to one another and secure the band about a human wrist;
• and
• a front side comprising an outer wrist material layer, wherein the front side is configured to face directionally away from the human wrist when fastened;
• and
• a rear side comprising an inner wrist material layer, wherein the wrist side is configured to face directionally towards the human wrist when fastened;
• a test portion side comprising a test portion slot, wherein the test portion slot is configured to be between and parallel to the outer wrist material layer and the inner wrist material layer when fastened to the human wrist;
• a disposable and removeable test strip base;
• a plurality of fields, wherein the plurality of fields are configured to be disposed on the test strip base and each field comprises a dried chemical substance, wherein the dried chemical substance is configured to discolor into a first color tone and a second color tone in response to contact with a knock-out drug, and wherein the knock-out drug comprises at least one of Gamma-Hydroxybutyrate, Ketamine, Rohypnol, Flunitrazepam, Alprazolam and Diazepam;
• a test field portion comprising the disposable and removeable test strip base and the plurality of fields, wherein the test field portion is configured to fit into the test portion slot;
• a normal state color tone comprising the first color tone, wherein the first color tone of the dried chemical substance is configured to be dry and visible before starting a test for the presence of a knock-out drug within a sample of a fluid;
• a positive state color tone comprising the second color tone, wherein the second color tone is different from the first color tone, wherein an application of the sample of the fluid to at least one of the fields of the plurality of fields causes the dried chemical substance to turn into the second color tone if the sample of the fluid contains the knock- out drug;
• a first opening, wherein the first opening is a viewing opening configured to be disposed on the front side of the band and to visually display the test field portion;
• and
• a second opening, wherein the second opening is a test portion opening configured to be disposed on the test portion side of the band and to allow the insertion and withdrawal of the test strip base from the test portion slot;
• fastening the bracelet around a human wrist via the closure mechanism;
• obtaining a sample of fluid from a container via an applicator;
• applying the sample of the fluid to at least one detection spot of the at least two detection spots via the applicator;
• and
• detecting the presence or absence of a knock-out drug within the sample of the fluid by observing a change of color tone of the at least one detection spot, wherein a second color tone of the at least detection spot indicates the presence of the knock-out drug in the sample of the fluid, and a third color tone of the at least one detection spot indicates the absence of the knock- out drug in the sample of the fluid;
• wherein the third color tone is different than the first color tone;
• wherein the knock-out drug comprises at least one of Gamma-Hydroxybutyrate, Ketamine, Rohypnol, Flunitrazepam, Alprazolam and Diazepam.